Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Carcinomas that develop in the pancreatic islets of transgenic mice expressing the SV40 T-antigens (Tag) under transcriptional control of the rat insulin II promoter (RIP) progress through well-characterized stages that are similar to aspects of human tumor progression, including hyperplastic growth, increased angiogenesis and reduced apoptosis. The latter two stages have been associated with recurrent loss of heterozygosity (LOH) and reduced genome copy number on chromosomes 9 (LOH9) and 16 (LOH16), aberrations which we believe contribute to these phenotypes. Earlier analyses localized LOH9 to approximately 3 Mb and LOH16 to approximately 30 Mb (both syntenic with human 3q21-q25) but were limited by low throughput and a lack of informative polymorphic markers. Here we show that comparative genomic hybridization to DNA microarrays (array CGH) overcomes these limitations by allowing efficient, genome-wide analyses of relative genome copy number. The CGH arrays used in these experiments carried BACs distributed at 2-20-MB intervals across the mouse genome and at higher density in regions of interest. Using array CGH, we further narrowed the loci for LOH9 and LOH16 and defined new or previously unappreciated recurrent regions of copy-number decrease on chromosomes 6, 8 and 14 (syntenic with human chromosomes 12p11-p13, 16q24.3 and 13q11-q32, respectively) and regions of copy-number increase on chromosomes 2 and 4 (syntenic to human chromosomes 20q13.2 and 1p32-p36, respectively). Our analyses of human genome sequences syntenic to these regions suggest that CYP24, PFDN4, STMN1, CDKN1B, PPP2R3 and FSTL1 are candidate oncogenes or tumor-suppressor genes. We also show that irradiation and genetic background influence the spectrum of aberrations present in these tumors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conventional mouse models driven by activated oncogenes or loss of tumor suppressor genes exhibited fewer focal CNAs, instead showing genomic profiles characterized by gain or loss of whole chromosomes (114-118).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [114]
Citations
Cites
Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
The sequence of the human genome
Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., et al. (2001) · Science · doi:10.1126/science.1058040 · Cited by 13,909
Pinkel, D., Segraves, R., Sudar, D., Clark, S., Poole, I., Kowbel, D., Collins, C., Kuo, W.-L., Chen, C., Zhai, Y., et al. (1998) · Nature Genetics · doi:10.1038/2524 · Cited by 2,240
Self-citationGenome-wide analysis of DNA copy-number changes using cDNA microarrays
Pollack, J. R., Perou, C. M., Alizadeh, A. A., Eisen, M. B., Pergamenschikov, A., Williams, C. F., Jeffrey, S. S., Botstein, D., & Brown, P. O. (1999) · Nature Genetics · doi:10.1038/12640 · Cited by 1,423
Telenius, H., Carter, N. P., Bebb, C. E., Nordenskjo¨ld, M., Ponder, B. A. J., & Tunnacliffe, A. (1992) · Genomics · doi:10.1016/0888-7543(92)90147-k · Cited by 1,418
Matrix-based comparative genomic hybridization: Biochips to screen for genomic imbalances
Solinas-Toldo, S., Lampel, S., Stilgenbauer, S., Nickolenko, J., Benner, A., Döhner, H., Cremer, T., & Lichter, P. (1997) · Genes, Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199712)20:4<399::aid-gcc12>3.0.co;2-i · Cited by 1,002
The murine gene p27Kip1 is haplo-insufficient for tumour suppression
Fero, M. L., Randel, E., Gurley, K. E., Roberts, J. M., & Kemp, C. J. (1998) · Nature · doi:10.1038/24179 · Cited by 784
Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene
Albertson, D. G., Ylstra, B., Segraves, R., Collins, C., Dairkee, S. H., Kowbel, D., Kuo, W.-L., Gray, J. W., & Pinkel, D. (2000) · Nature Genetics · doi:10.1038/75985 · Cited by 589
Self-citationPrefoldin, a Chaperone that Delivers Unfolded Proteins to Cytosolic Chaperonin
Vainberg, I. E., Lewis, S. A., Rommelaere, H., Ampe, C., Vandekerckhove, J., Klein, H. L., & Cowan, N. J. (1998) · Cell · doi:10.1016/s0092-8674(00)81446-4 · Cited by 565
Beta-cell lines derived from transgenic mice expressing a hybrid insulin gene-oncogene.
Efrat, S., Linde, S., Kofod, H., Spector, D., Delannoy, M., Grant, S., Hanahan, D., & Baekkeskov, S. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.9037 · Cited by 515
Self-citation
Cited by
Items 101–200 of 296
Characterizing the physical genome
Pollack, J. R., & Iyer, V. R. (2002) · Nature Genetics · doi:10.1038/ng1035 · Cited by 69
Ballif, B. C., Kashork, C. D., Saleki, R., Rorem, E. A., Sundin, K., Bejjani, B. A., & Shaffer, L. G. (2006) · Prenatal Diagnosis · doi:10.1002/pd.1411 · Cited by 65
“We used a dye-reversal strategy on two separate microarrays in which 500 ng each of test subject and reference control DNAs were labeled (Bio Prime DNA labeling System, Invitrogen, Carlsbad, CA) with Cyanine3 (Cy3) or Cyanine5 (Cy5), respectively (Hodgson et al., 2001).”
MethodTIMP-1 Alters Susceptibility to Carcinogenesis
Rhee, J.-S., Diaz, R., Korets, L., Hodgson, J. G., & Coussens, L. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2445 · Cited by 64
Mantripragada, K. K., Thuresson, A., Piotrowski, A., de Ståhl, T. D., Menzel, U., Grigelionis, G., Ferner, R. E., Griffiths, S., Bolund, L., Mautner, V., et al. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2005.033795 · Cited by 62
Reciprocal translocations: a trap for cytogenetists?
Ciccone, R., Giorda, R., Gregato, G., Guerrini, R., Giglio, S., Carrozzo, R., Bonaglia, M. C., Priolo, E., Laganà, C., Tenconi, R., et al. (2005) · Human Genetics · doi:10.1007/s00439-005-1324-x · Cited by 59
“) (Hodgson et al. 2001).”
MethodTan, X., Zhai, Y., Chang, W., Hou, J., He, S., Lin, L., Yu, Y., Xu, D., Xiao, J., Ma, L., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23637 · Cited by 58
Fstl1/DIP2A/MGMT signaling pathway plays important roles in temozolomide resistance in glioblastoma
Nie, E., Miao, F., Jin, X., Wu, W., Zhou, X., Zeng, A., Yu, T., Zhi, T., Shi, Z., Wang, Y., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0596-2 · Cited by 61
Cytogenetics in reproductive medicine: The contribution of comparative genomic hybridization (CGH)
Wells, D., & Levy, B. (2003) · BioEssays · doi:10.1002/bies.10232 · Cited by 58
A pseudolikelihood approach for simultaneous analysis of array comparative genomic hybridizations
Engler, D. A. (2005) · Biostatistics · doi:10.1093/biostatistics/kxj015 · Cited by 57
“For example, Hodgson et al. (2001) assumed that the data from a given chromosome for a given hybridization are distributed as a threecomponent (loss, no-change, and gain) Gaussian mixture.”
BackgroundCowell, J. K., Matsui, S., Wang, Y. D., LaDuca, J. R., Conroy, J. M., McQuaid, D., & Nowak, N. J. (2004) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2003.09.012 · Cited by 56
Steiner, Q., Otten, L., Hicks, J. M., Kaya, G., Grosjean, F., Säuberli, E., Lavanchy, C., Beermann, F., McClain, K. L., & Acha‐Orbea, H. (2007) · Blood · doi:10.1182/blood-2007-06-097576 · Cited by 54
Shakhova, O., Leung, C., van Montfort, E. H. N., Berns, A. J. M., & Marino, S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3545 · Cited by 58
Weber, B. L. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00026-0 · Cited by 54
Expression of CLDN1 in colorectal cancer: A novel marker for prognosis
Mori, M. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1102 · Cited by 58
“Several adjuvant chemotherapies are helpful in certain disease stages, especially in CRC, and indicate the usefulness of less invasive surgery for CRC (28,31-40).”
BackgroundArray comparative genomic hybridization in global developmental delay
Shevell, M. I., Bejjani, B. A., Srour, M., Rorem, E. A., Hall, N., & Shaffer, L. G. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30730 · Cited by 57
“…(the SignatureChip1; Signature Genomic Laboratories, Spokane, WA) that was developed for the detection of micro-deletions, micro-duplications, aneuploidy, unbalanced translocations, and subtelomeric and pericentromeric copy-number alterations (i.e., sub-microscopic CNC) [Hodgson et al., 2001].”
BackgroundMethodInfluentialHodgson, J. G., Malek, T. B., Bornstein, S., Hariono, S., Ginzinger, D. G., Muller, W. J., & Gray, J. W. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0755 · Cited by 64
“frozenmammary tumor tissue as described (17).”
Self-citationAssay of Rab25 Function in Ovarian and Breast Cancers
Cheng, K. W., Lu, Y., & Mills, G. B. (2005) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)03017-x · Cited by 50
Zhou, Y., Luoh, S.-M., Zhang, Y., Watanabe, C. K., Wu, T. D., Ostland, M., Wood, W. I., & Zhang, Z. (2003) · PubMed · Cited by 50
Buckley, P. G., Jarbo, C., Menzel, U., Mathiesen, T. I., Scott, C., Gregory, S. G., Langford, C. F., & Dumanski, J. P. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3651 · Cited by 49
Shared acquired genomic changes in zebrafish and human T-ALL
Rudner, L. A., Brown, K. H., Dobrinski, K. P., Bradley, D. F., Garcia, M. I., Smith, A. C. H., Downie, J. M., Meeker, N. D., Look, A. T., Downing, J. R., et al. (2011) · Oncogene · doi:10.1038/onc.2011.138 · Cited by 53
“To detect acquired copy number aberrations (CNAs), array comparative genomic hybridization (aCGH) has been widely applied to human cancers (Pinkel and Albertson, 2005) and is likewise amenable to model organisms (Hodgson et al., 2001; Maydan et al., 2007; Thomas et al., 2007).”
BackgroundChen, J., & Wang, Y. (2008) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2008.129 · Cited by 47
“The copy number alterations in mouse islet carcinomas were studied using aCGH technique in [7] and the resulting aCGH data were analyzed for DNA copy number changes by a finite Gaussian mixture model with three components (a “no change” component, a “loss” component, and a “gain” component).”
BackgroundMethodM-CGH: Analysing microarray-based CGH experiments
Wang, J., Meza‐Zepeda, L. A., Kresse, S. H., & Myklebost, O. (2004) · BMC Bioinformatics · doi:10.1186/1471-2105-5-74 · Cited by 46
“We accomplish this by using a maximum likelihood method to fit a mixture of three Gaussian distributions (representing amplifications, normal and deletion) to a histogram of normalized log 2 CGH ratios from the array CGH analysis [3].”
MethodActivins and follistatins: Emerging roles in liver physiology and cancer
Kreidl, E., Öztürk, D. G., Metzner, T., Berger, W., & Grusch, M. (2009) · World Journal of Hepatology · doi:10.4254/wjh.v1.i1.17 · Cited by 46
A genetic strategy to overcome the senescence of primary meningioma cell cultures
Baía, G. S., Slocum, A. L., Hyer, J. D., Misra, A., Sehati, N., VandenBerg, S. R., Feuerstein, B. G., Deen, D. F., McDermott, M. W., & Lal, A. (2006) · Journal of Neuro-Oncology · doi:10.1007/s11060-005-9076-y · Cited by 45
Genomic approaches to identification of tumour-susceptibility genes using mouse models
Mao, J., & Balmain, A. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(03)00005-4 · Cited by 44
Detection of DNA copy number alterations in cancer by array comparative genomic hybridization
Michels, E., Preter, K. D., Roy, N. V., & Speleman, F. (2007) · Genetics in Medicine · doi:10.1097/gim.0b013e318145b25b · Cited by 50
Wang, D., Zhu, Z.-Z., Jiang, H., Zhu, J., Cong, W., Wen, B., He, S.-Q., & Liu, S.-F. (2015) · Hepatology International · doi:10.1007/s12072-015-9642-0 · Cited by 42
Glioma Test Array for Use with Formalin-Fixed, Paraffin-Embedded Tissue
Mohapatra, G., Betensky, R. A., Miller, E. R., Carey, B., Gaumont, L. D., Engler, D. A., & Louis, D. N. (2006) · Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2006.050109 · Cited by 42
Bayesian Random Segmentation Models to Identify Shared Copy Number Aberrations for Array CGH Data
Baladandayuthapani, V., Ji, Y., Talluri, R., Nieto-Barajas, L. E., & Morris, J. S. (2010) · Journal of the American Statistical Association · doi:10.1198/jasa.2010.ap09250 · Cited by 41
“Hodgson et al. (2001) proposed a three-component Gaussian mixture model corresponding to gain, loss, or neutral states, respectively.”
BackgroundCarter, N. P., Fiegler, H., & Piper, J. (2002) · Cytometry · doi:10.1002/cyto.10153 · Cited by 41
Current status and future prospects of array-based comparative genomic hybridisation
Snijders, A. M. (2003) · Briefings in Functional Genomics and Proteomics · doi:10.1093/bfgp/2.1.37 · Cited by 39
O’Hagan, R. C., Brennan, C., Strahs, A. L., Zhang, X., Kannan, K., Donovan, M., Cauwels, C., Sharpless, N. E., Wong, W. H., & Chin, L. (2003) · PubMed · Cited by 39
Targets of genome copy number reduction in primary breast cancers identified by integrative genomics
Chen, W., Salto‐Tellez, M., Palanisamy, N., Ganesan, K., Hou, Q., Tan, L. K., Sii, L. H., Ito, K., Tan, B. K. T., Wu, J., et al. (2006) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20411 · Cited by 38
“To identify the key ‘‘driver’’ genetic loci targeted by these chromosomal abnormalities, investigators have used platforms that include comparative genomic hybridization (CGH) and high-resolution array-based CGH (aCGH), which measure relative genome copy number (CN) in tumor samples at resolutions ranging from 3 Mb to…”
MethodMSB: A mean-shift-based approach for the analysis of structural variation in the genome
Wang, L.-Y., Abyzov, A. S., Korbel, J. O., Snyder, M. P., & Gerstein, M. (2008) · Genome Research · doi:10.1101/gr.080069.108 · Cited by 39
Jackson‐Grusby, L. (2002) · Oncogene · doi:10.1038/sj.onc.1205603 · Cited by 39
“Comparative genomic hybridization has been implemented using the microarray platform (Pollack et al., 1999), and applied to a mouse islet cell tumor model to identify loci that were either amplified or exhibited LOH in tumors (Hodgson et al., 2001).”
MethodHeetebrij, R. J., Talman, E. G., van Velzen, M. A., van Gijlswijk, R. P. M., Snoeijers, S. S., Schalk, M., Wiegant, J. C. A. G., Rijke, F. V. D., Kerkhoven, R. M., Raap, A. K., et al. (2003) · ChemBioChem · doi:10.1002/cbic.200200498 · Cited by 34
van Dekken, H., Vissers, K. J., Tilanus, H. W., Kuo, W. L., Tanke, H. J., Rosenberg, C., IJszenga, M. J., & Szuhai, K. (2006) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2005.11.002 · Cited by 34
Fujita, A., Gomes, L. R., Sato, J. R., Yamaguchi, R., Thomaz, C. E., Sogayar, M. C., & Miyano, S. (2008) · BMC Systems Biology · doi:10.1186/1752-0509-2-106 · Cited by 36
“00092 [91] 59 HSPCB heat shock protein 90 kDa alpha (cytosolic) class B member 1 0.”
Reconstructing tumor amplisomes
Raphael, B. J., & Pevzner, P. A. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth931 · Cited by 34
“…in tumor genomes results from comparative genome hybridization (CGH) experiments (Kallioniemi et al., 1992), and more recently from higher resolution array-based techniques, such as array-CGH (Hodgson et al., 2001) and Bacterial artificial chromosome (BAC) arrays (Snijders et al., 2001).”
BackgroundThe performance of CGH array for the detection of cryptic constitutional chromosome imbalances
Schoumans, J., Anderlid, B.-M., Blennow, E., Teh, B. T., & Nordenskjöld, M. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.013920 · Cited by 33
Abnormal Expression of PFDN4 in Colorectal Cancer: A Novel Marker for Prognosis
Miyoshi, N., Ishii, H., Mimori, K., Nishida, N., Tokuoka, M., Akita, H., Sekimoto, M., Doki, Y., & Mori, M. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-1138-5 · Cited by 32
Hepatic activation and inactivation of clinically-relevant vitamin D analogs and prodrugs.
Jones, G., Byford, V., West, S., 増田, 園., Ibrahim, G., Kaufmann, M., Knutson, J. C., Strugnell, S. A., & Mehta, R. G. (2006) · PubMed · Cited by 32
A canine cancer-gene microarray for CGH analysis of tumors
Thomas, R. J., Fiegler, H., Ostrander, E. A., Galibert, F., Carter, N. P., & Breen, M. (2003) · Cytogenetic and Genome Research · doi:10.1159/000075758 · Cited by 32
“A variety of approaches have been used in the development of genomic microarrays (Solinas-Toldo et al., 1997; Pinkel et al., 1998; Albertson et al., 2000; Hodgson et al., 2001; Snidjers et al., 2001).”
BackgroundCasanovas, O., Hager, J. H., Chun, M. G. H., & Hanahan, D. (2005) · Oncogene · doi:10.1038/sj.onc.1208823 · Cited by 31
Self-citationNolan-Stevaux, O., Truitt, M. C., Pahler, J. C., Olson, P., Guinto, C., Lee, D. C., & Hanahan, D. (2010) · Genes & Cancer · doi:10.1177/1947601909358722 · Cited by 31
“0 cM) is not amplified in RT2 malignancies.(28) To determine whether mutations in the kinase domain could account for the sensitivity of these PNET tumors to EGFR inhibitors, we sequenced the kinase domain of Egfr from 6 independent tumors.”
MethodSelf-citationCowell, J. K., Wang, Y. D., Head, K. L., Conroy, J. M., McQuaid, D., & Nowak, N. J. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601588 · Cited by 31
“This approach is referred to as array comparative genome hybridisation (CGHa), and consists of a series of mapped BACs arrayed on a glass slide to which DNA from test and control samples are competitively hybridised (Hodgson et al, 2001; Snidjers et al, 2001; Cowell and Nowak, 2003).”
BackgroundNagy, J., Feh�r, L. Z., Sonkodi, I., Leszny�k, J., Iv�nyi, B., & Pusk�s, L. G. (2005) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-004-1176-0 · Cited by 30
Jagged1 DNA Copy Number Variation Is Associated with Poor Outcome in Liver Cancer
Kawaguchi, K., Honda, M., Yamashita, T., Okada, H., Shirasaki, T., Nishikawa, M., Nio, K., Arai, K., Sakai, Y., Yamashita, T., et al. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.04.011 · Cited by 30
“2062 basedeCGH.(6,14) Amplified or deleted regions are found in various types of cancers, but these specific abnormal regions differ in different organs.”
BackgroundDetailed assessment of chromosome 22 aberrations in sporadic pheochromocytoma using array‐CGH
Jarbo, C., Buckley, P. G., Piotrowski, A., Mantripragada, K. K., Benetkiewicz, M., de Ståhl, T. D., Langford, C. F., Gregory, S. G., Dralle, H., Gimm, O., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21385 · Cited by 29
Detecting Copy Number Changes in Genomic DNA: MAPH and MLPA
White, S. J., Breuning, M. H., & den Dunnen, J. T. (2004) · Methods in cell biology · doi:10.1016/s0091-679x(04)75032-3 · Cited by 33
“Samples were analyzed using a combination of methods described for analysis of MAPH (Armour et al. 2000; Sismani et al. 2001) and array-based comparative genomic hybridization (Hodgson et al. 2001) experiments.”
MethodGenomic instability in radiation-induced mouse lymphoma from p53 heterozygous mice
Mao, J., Li, J., Jiang, T., Li, Q., Wu, D., Pérez‐Losada, J., Delrosario, R., Peterson, L. E., Balmain, A., & Cai, W. (2005) · Oncogene · doi:10.1038/sj.onc.1208926 · Cited by 30
“Previous CGH array approaches using both mouse and human clones, although genome wide, had a resolution of approximately one BAC clone per 1–3Mb (Hodgson et al., 2001; Cai et al., 2002).”
Ammerlaan, A. C. J., de Bustos, C., Ararou, A., Buckley, P. G., Mantripragada, K. K., Verstegen, M. J. T., Hulsebos, T. J. M., & Dumanski, J. P. (2005) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20207 · Cited by 28
“Several array-CGH articles have reported the reliable detection of genetic aberrations on a heterogeneous cell background in the context of mouse tumor cell lines, human schwannomas, and ovarian cancer as well as in meningiomas (Hodgson et al., 2001; Mantripragada et al., 2003a; Benetkiewicz et al., 2004; Buckley et a…”
BackgroundANXA9 gene expression in colorectal cancer: A novel marker for prognosis
Miyoshi, N., Yamamoto, H., Mimori, K., Yamashita, S., Miyazaki, S., Nakagawa, S., Ishii, H., Noura, S., Ohue, M., Yano, M., et al. (2014) · Oncology Letters · doi:10.3892/ol.2014.2477 · Cited by 27
“Several adjuvant chemotherapies are valuable in specific stages of CRC and indicate the usefulness of less invasive surgery for the disease (17-20,22-28).”
SV40 TAg mouse models of cancer
Colvin, E. K., Weir, C., Ikin, R. J., & Hudson, A. L. (2014) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2014.02.004 · Cited by 26
García‐Escudero, R., Martínez‐Cruz, A. B., Santos, M., Lorz, C., Segrelles, C., Garaulet, G., Sáiz-Ladera, C., Costa, C., Buitrago-Pérez, Á., Dueñas, M., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-193 · Cited by 26
“Cross-species studies using genomic-based technologies have indicated the preservation of oncogene transcriptional signatures [1,2] or the synteny of tumor-associated copy number alterations [3-5].”
Gene-resolution analysis of DNA copy number variation using oligonucleotide expression microarrays
Auer, H., Newsom, D. L., Nowak, N. J., McHugh, K. M., Singh, S., Yu, C. Y., Yang, Y., Wenger, G. D., Gastier, J. M., & Kornacker, K. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-111 · Cited by 26
“Background Array-based comparative genomic hybridization (aCGH) allows the identification of genome-wide DNA gains and losses in cancers and genetic diseases [1-3].”
Exploiting noise in array CGH data to improve detection of DNA copy number change
Hu, J., Gao, J., Cao, Y., Böttinger, E. P., & Zhang, W. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl730 · Cited by 26
Seifert, M., Gohr, A., Marc Strickert, A., & Große, I. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002286 · Cited by 32
“data have been developed including approaches based on Gaussian mixture models [18], circular binary segmentation [19–21], genetic local search algorithms [22,23], dynamic programming [24–26], hierarchical clustering [27], sparse Bayesian learning [28], variational methods [29,30], smoothing techniques [31–34], regres…”
MethodDetecting Cancer Gene Networks Characterized by Recurrent Genomic Alterations in a Population
Efroni, S., Ben‐Hamo, R., Edmonson, M. N., Greenblum, S. I., Schaefer, C. F., & Buetow, K. H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014437 · Cited by 26
“Chin et als [1] CGH array annotations provided rough genomic positions (in megabases) whose coordinates aligned most closely with an older genome build, hg16.”
MethodInfluentialBocciardi, R., Giorda, R., Marigo, V., Zordan, P., Montanaro, D., Gimelli, S., Seri, M., Lerone, M., Ravazzolo, R., & Gimelli, G. (2005) · Human Mutation · doi:10.1002/humu.20235 · Cited by 25
“We used a dye-reversal strategy (dye-swap) on two different microarrays for Cyanine3 (Cy3) and Cyanine5 (Cy5) dye-labeled DNA from the control and patient (BioPrime DNA labeling system; Invitrogen; Carlsbad, CA; www.invitrogen.com) [Hodgson et al., 2001].”
MethodHager, J. H., Hodgson, J., Fridlyand, J., Hariono, S., Gray, J. W., & Hanahan, D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3522 · Cited by 25
“The recurrent CNAs of the three inbred (B6, C3H, and FVB) RIP1-Tag2 sublines were similar to those detected in an earlier study (9).”
BackgroundMethodResultSelf-citationNiwa, T., Yamashita, S., Tsukamoto, T., Kuramoto, T., Nomoto, T., Wakazono, K., Fujita, H., Matsushima, T., Tatematsu, M., Sügimura, T., et al. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00068.x · Cited by 24
Measurement and relevance of neuroblastoma DNA copy number changes in the post-genome era
Mossé, Y. P., Greshock, J. D., Weber, B. L., & Maris, J. M. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.02.052 · Cited by 24
Scacheri, P. C., Kennedy, A. L., Chin, K., Miller, M. T., Hodgson, J. G., Gray, J. W., Marx, S. J., Spiegel, A. M., & Collins, F. S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1648 · Cited by 24
Self-citationChen, W., Yuan, L., Cai, Y., Chen, X., Chi, Y., Wei, P., Zhou, X., & Shi, D. (2013) · Genomics · doi:10.1016/j.ygeno.2013.02.003 · Cited by 23
Fiegler, H., Redon, R., & Carter, N. P. (2007) · Nature Protocols · doi:10.1038/nprot.2007.53 · Cited by 22
Langland (2010) · Oncology Reports · doi:10.3892/or_00000728 · Cited by 22
A robust Correntropy-based method for analyzing multisample aCGH data
Mohammadi, M., Hodtani, G. A., & Yassi, M. (2015) · Genomics · doi:10.1016/j.ygeno.2015.07.008 · Cited by 21
Cancer gene discovery in mouse and man
Mattison, J., van der Weyden, L., Hubbard, T., & Adams, D. J. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.03.001 · Cited by 30
Chun, M. G. H., Mao, J., Chiu, C. W., Balmain, A., & Hanahan, D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012705107 · Cited by 22
“Previous studies have documented that tumors isolated from RT2 mice undergo chromosomal gains and losses at different frequencies dependent on genetic background (10, 24).”
BackgroundSelf-citationConstruction and application of a zebrafish array comparative genomic hybridization platform
Freeman, J. L., Ceol, C. J., Feng, H., Langenau, D. M., Belair, C. D., Stern, H. M., Song, A., Paw, B. H., Look, A. T., Zhou, Y., et al. (2008) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20623 · Cited by 22
“VC 2008 Wiley-Liss, Inc.”
BackgroundNilsson, B., Johansson, M., Heyden, A., Nelander, S., & Fioretos, T. (2008) · Genome biology · doi:10.1186/gb-2008-9-1-r13 · Cited by 21
Mapping of the chromosomal amplification 1p21-22 in bladder cancer
Scaravilli, M., Asero, P., Tammela, T. L. J., Visakorpi, T., & Saramäki, O. R. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-547 · Cited by 19
“The development of array-based technologies for CGH [9,10] led to > 10-fold increase of the resolution and consequently to the analysis of copy number alterations at single gene level.”
BackgroundSt‐Arnaud, R. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-381978-9.10004-6 · Cited by 19
Translational challenges in pancreatic neuroendocrine tumor immunotherapy
Egal, É. S. A., Jacenik, D., Soares, H. P., & Beswick, E. J. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188640 · Cited by 21
Integration of genomic technologies for accelerated cancer drug development
Basik, M., Mousses, S., & Trent, J. M. (2003) · BioTechniques · doi:10.2144/03353dd01 · Cited by 18
Array comparative genomic hybridization with cyanin cis -platinum-labeled DNAs
Raap, A. K., van der Burg, M. J., Knijnenburg, J., Meershoek, E. J., Rosenberg, C., Gray, J. W., Wiegant, J. C. A. G., Hodgson, J., & Tanke, H. J. (2004) · BioTechniques · doi:10.2144/04371dd03 · Cited by 18
Self-citationSelective Inference for Change Point Detection in Multi-dimensional SequencesPreprint
Umezu, Y., & Takeuchi, I. (2017) · arXiv (Cornell University) · doi:10.48550/arxiv.1706.00514 · Cited by 18
“In this study, CNVs of 46 patients diagnosed with diffuse large B-cell lymphoma (DLBCL) were investigated by an array comparative genomic hybridization (array CGH) technique (Hodgson et al., 2001).”
MethodDevelopment of a DNA-labeling system for array-based comparative genomic hybridization.
Lieu, P. T., Jozsi, P., Gilles, P. N., & Peterson, T. (2005) · PubMed Central · Cited by 17
van Duin, M., van Marion, R., Watson, J. E. V., Paris, P. L., Lapuk, A. V., Brown, N., Oseroff, V. V., Albertson, D. G., Pinkel, D., de Jong, P., et al. (2004) · Cytometry Part A · doi:10.1002/cyto.a.20102 · Cited by 17
“The DOP PCR used in this study has been shown to be an effective solution for generating sufficient quantities of DNA for spotting microarrays (37,43).”
MethodSelf-citationClinical implications of advanced molecular cytogenetics in cancer
Mundle, S. D., & Sokolova, I. A. (2004) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.4.1.71 · Cited by 17
Discovering Tumor Suppressor Genes Through Genome-Wide Copy Number Analysis
Rothenberg, S. M., & Settleman, J. (2010) · Current Genomics · doi:10.2174/138920210791616734 · Cited by 18
“A variety of computational methods have been developed to “automatically” delineate genomic regions of gains from probe-level data [26,39-49].”
Argilla, D., Chin, K., Singh, M., Hodgson, J. G., Bosenberg, M., Ortíz-de-Solórzano, C., Lockett, S. J., DePinho, R. A., Gray, J. W., & Hanahan, D. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.08.032 · Cited by 19
Self-citationTaguchi, R., Yamada, M., Horiguchi, K., Tomaru, T., Ozawa, A., Shibusawa, N., Hashimoto, K., Okada, S., Satoh, T., & Mori, M. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.10.077 · Cited by 16
Gene dosage change of TPTE and BAGE2 and breakpoint analysis in Robertsonian Down syndrome
Shaw, S., Chen, C., Cheng, P.-J., Wang, T., Hou, J., Lin, C., Chang, S., Hwa, H., Lin, J., Chao, A., et al. (2007) · Journal of Human Genetics · doi:10.1007/s10038-007-0229-z · Cited by 16
“Array-based comparative genomic hybridization (CGH) allows identification of chromosome regions of gains and losses in cancers and genetics diseases (Pinkel et al. 1998; Pollack et al. 1999; Hodgson et al. 2001; Snijders et al. 2001; Greshock et al. 2004).”
Chen, C., Bao, Y., Ju, S., Jiang, C., Zou, X., Zhang, X., & Chen, L. (2024) · Biomarker Research · doi:10.1186/s40364-024-00603-y · Cited by 15
“Furthermore, empiri - cal evidence has supported that PFDN4 may be associated with the progression of cancer progressions [70–72].”
BackgroundDetection and interpretation of genomic structural variation in health and disease
Vandeweyer, G., & Kooy, R. F. (2013) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.12.119 · Cited by 19
Bayraklı, F., Bilgüvar, K., Mason, C. E., DiLuna, M. L., Bayri, Y., Güngör, L., Terzi, M., Mane, S., Lifton, R. P., State, M. W., et al. (2007) · Human Mutation · doi:10.1002/humu.20592 · Cited by 15
“…increasingly useful tool in identifying both normal cytogenetic variation as well as in the characterization of chromosomal abnormalities associated with developmental delay and cancer [Fridlyand et al., 2006; Hodgson et al., 2001; Pinkel et al., 1998; Redon et al., 2006; Shaw-Smith et al., 2006].”
MethodIizuka, D., Imaoka, T., Takabatake, T., Nishimura, M., Kakinuma, S., Nishimura, Y., & Shimada, Y. (2010) · Radiation Research · doi:10.1667/rr2006.1 · Cited by 17
Brookman-Amissah, N., Duchesnes, C., Williamson, M. P., Wang, Q., Ahmed, A., Feneley, M. R., Mackay, A. G., Freeman, A., Fenwick, K., Iravani, M., et al. (2005) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500826 · Cited by 15
Takabatake, T., Kakinuma, S., Hirouchi, T., Nakamura, M. M., Fujikawa, K., Nishimura, M., Oghiso, Y., Shimada, Y., & Tanaka, K. J. (2008) · Radiation Research · doi:10.1667/rr1180.1 · Cited by 15
MAPH: from gels to microarrays
Patsalis, P. C., Kousoulidou, L., Sismani, C., Männik, K., & Kurg, A. (2005) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2005.04.011 · Cited by 15
“Microarray-based CGH has been performed successfully to screen the total genome to identify subtle abnormalities in both malignancies and constitutional disorders [12,17,24].”
MethodComputational BAC clone contig assembly for comprehensive genome analysis
Lapuk, A. V., Volik, S. V., Vincent, R., Chin, K., Kuo, W., de Jong, P., Collins, C. C., & Gray, J. W. (2004) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20016 · Cited by 15
Self-citationSander, S., Bullinger, L., Karlsson, A. E., Giuriato, S., Hernandez‐Boussard, T., Felsher, D. W., & Pollack, J. R. (2005) · Oncogene · doi:10.1038/sj.onc.1208751 · Cited by 15
MACC1 expression levels as a novel prognostic marker for colorectal cancer
Yamamoto, H., Miyoshi, N., Mimori, K., Hitora, T., Tokuoka, M., Fujino, S., Ellis, H., Ishii, H., Noura, S., Ohue, M., et al. (2014) · Oncology Letters · doi:10.3892/ol.2014.2460 · Cited by 13
“In CRC, various adjuvant chemotherapeutic strategies are facilitative during certain disease stages and indicate the usefulness of less invasive surgery for CRC (13,16-18,20-26).”
An integrated Bayesian analysis of LOH and copy number data
Rancoita, P. M. V., Hütter, M., Bertoni, F., & Kwee, I. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-321 · Cited by 13
“Similarly to [33], we model this density as a mixture of normal distributions (a way to estimate this mixture density can be found in Section S.”
MethodApplication of microarray-based technology to neuroblastoma
Scaruffi, P., Valent, A., Schramm, A. R., Astrahantseff, K., Eggert, A., & Tonini, G. P. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.01.052 · Cited by 13
Zhang, Y., Xu, X., Yang, Y., Ma, J., Wang, L., Meng, X., Chen, B., Qin, L., Lu, T., & Gao, Y. (2018) · Journal of Breast Cancer · doi:10.4048/jbc.2018.21.e43 · Cited by 13
“FSTL1 has been shown to possess antiangiogenic activity in pancreatic cancer [15] and predicts a poor prognosis in metastatic clear-cell renal cell carcinoma [16].”
BackgroundZvara, Á., Hackler, L., Nagy, B. Z., Micsík, T., & Puskás, L. G. (2002) · Pathology & Oncology Research · doi:10.1007/bf03036737 · Cited by 13
Reid, A. G., Tarpey, P. S., & Nacheva, E. P. (2003) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10215 · Cited by 13
“Whereas several recent reports have highlighted the value of array CGH to the field of cancer biology (Albertson et al., 2000; Hodgson et al., 2001; Massion et al., 2002), the MAPH technique, designed and successfully used to quantify constitutional genomic imbalance, has not been applied to tumor…”
BackgroundMethod
Metadata
- Authors
- Hodgson, G., Hager, J. H., Volik, S., Hariono, S., Wernick, M., Moore, D., Albertson, D. G., Pinkel, D., Collins, C., Hanahan, D., & Gray, J. W.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Gray, Joe W.
- Venue
- Nature Genetics
- Published
- 2001-11-05
- Volume
- 29
- Issue
- 4
- Pages
- 459-464
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1520880567
- Cited by
- 294
- References
- 26
- Citations by year
- 2024: 6 · 2023: 1 · 2021: 1 · 2020: 2 · 2018: 3 · 2017: 4 · 2016: 5 · 2015: 7 · 2014: 10 · 2013: 3 · 2012: 5
- FWCI
- 15.83
- Type
- journal article
- Language
- en
- Update notices
- correction (2001-12-01)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ca078601-02)
- U.S. Public Health Service
- University of California, San Francisco
- National Cancer Institute (CA82103, R37-CA45234, CA78601, P30CA082103, R37CA045234)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Keywords
- SV40 T antigen, loss of heterozygosity, chromosome 9, chromosome 16, copy number alterations, array comparative genomic hybridization, tumor suppressor, oncogenes, CYP24, STMN1, p27, FSTL1, genetic background, irradiation, mouse tumor model
- MeSH terms
- Animals, Base Sequence, Humans, Islets of Langerhans, Mice, Transgenic, Nucleic Acid Hybridization, Pancreatic Neoplasms, Genome, DNA Primers, Loss of Heterozygosity, Oligonucleotide Array Sequence Analysis, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.